C12Y 304/21001
Chymotrypsin
Official title: Chymotrypsin (3.4.21.1)
C12Y304/21001 (Chymotrypsin) appears on 79 US grants and 118 published applications in this corpus.
Search patents in C12Y- Granted patents
- 79
- Published applications
- 118
- Assignees
- 45
- Inventors
- 172
- Latest grant
- 25 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 1 | 2 |
| 2007 | 0 | 3 |
| 2008 | 0 | 3 |
| 2009 | 0 | 7 |
| 2010 | 0 | 5 |
| 2011 | 3 | 2 |
| 2012 | 4 | 8 |
| 2013 | 2 | 2 |
| 2014 | 5 | 4 |
| 2015 | 6 | 12 |
| 2016 | 6 | 10 |
| 2017 | 11 | 9 |
| 2018 | 5 | 5 |
| 2019 | 5 | 10 |
| 2020 | 3 | 6 |
| 2021 | 7 | 8 |
| 2022 | 3 | 8 |
| 2023 | 4 | 7 |
| 2024 | 4 | 1 |
| 2025 | 3 | 2 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Enzyme based compositions and methods for removing dental calculi25 Nov 2025US 12,478,571 B2Pontis Biologics, Inc.
- Proenzyme composition23 Sep 2025US 12,419,938 B2Propanc Pty Ltd
- Purified fish proteases with high specific activities and its process of production10 Jun 2025US 12,325,868 B2Bioseutica B.V.
- Injectable composition for preventing hair loss or stimulating hair growth29 Oct 2024US 12,128,130 B2Keramedix Inc.
- Method for preparing biomaterial having selectively functionalized tyrosine, biomaterial having selectively functionalized tyrosine, and pharmaceutical composition containing same as active ingredient22 Oct 2024US 12,122,812 B2Seoul National University R&Db Foundation
- Compositions and methods relating to recombinant chymotrypsin7 May 2026US 2026/0125664 A1Promega Corporation
- Crystallisation of a protein capable of crystallizing under salting-in conditions using multiple protein feeds9 Apr 2026US 2026/0098057 A1
- Enzyme based compositions and methods for removing dental calculi15 Jan 2026US 2026/0014067 A1Pontis Biologics, Inc.
- Peptide and use thereof9 Oct 2025US 2025/0312407 A1Ajinomoto Co., Inc.
- Synthesis of self-assembling artificial proteins utilizing a host-guest system and uses thereof7 Aug 2025US 2025/0250302 A1Indian Institute of Science Education and Research, Pune (IISER Pune)
Most cited
By later US patents
- Methods for treating pervasive development disorders63US 6,632,429 B12003
- Method for treating pervasive development disorders63US 8,105,584 B2Curemark, LLC · 2012
- Methods of treating pervasive development disorders54US 8,012,930 B2Curemark, LLC · 2011
- Method for identifying autistic individuals amenable to digestive enzyme therapy53US 8,008,036 B2Curemark, LLC · 2011
- Method for identifying individuals having a pervasive development disorder amenable to digestive enzyme therapy50US 8,211,661 B2Curemark, LLC · 2012